BRAF and neoplasm: Both before and after matching, there were no significant differences between the two groups in sex, age, underlying thyroid diseases, tumor location, proximity of the tumor to the capsule, degree of tumor-capsule contact, blood flow, calcification, or BRAF gene mutation.